CDKN1B and breast carcinoma: The oncogenic miRNA, miR-221, is one of the few miRNAs that are persistently elevated in malignancies of different tissue including breast cancer[117], and has been suggested to accelerate cancer progression by targeting cell cycle regulators such as p57 and p27 [Figure 1][69-71].